MAX-40279 Uses, Dosage, Side Effects and more
MAX-40279 is under investigation in clinical trial NCT03412292 (MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)).
| Trade Name | MAX-40279 |
| Generic | MAX-40279 |
| Type | |
| Formula | C22H23FN6OS |
| Weight | Average: 438.53 Monoisotopic: 438.163808722 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
